4-(2-aminoethyl)benzenesulfonylfluoride has been researched along with Status Epilepticus in 1 studies
Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, S | 1 |
| Hamil, N | 1 |
| Abramov, AY | 1 |
| Walker, MC | 1 |
| Kovac, S | 1 |
1 other study available for 4-(2-aminoethyl)benzenesulfonylfluoride and Status Epilepticus
| Article | Year |
|---|---|
Status epilepticus results in persistent overproduction of reactive oxygen species, inhibition of which is neuroprotective.
Topics: Animals; Brain; Cell Death; Cells, Cultured; Glutathione; Male; NADPH Oxidases; Neurons; Neuroprotec | 2015 |